dexmedetomidine has been researched along with Hepatic Encephalopathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Du, J; Feng, JG; Jia, J; Liu, KX; Tan, SL; Zhang, Y; Zhou, J | 1 |
1 other study(ies) available for dexmedetomidine and Hepatic Encephalopathy
| Article | Year |
|---|---|
Dexmedetomidine alleviates neuroinflammation, restores sleep disorders and neurobehavioral abnormalities in rats with minimal hepatic encephalopathy.
Topics: Adrenergic alpha-2 Receptor Agonists; Ammonia; Animals; Anti-Inflammatory Agents; Anxiety; Behavior, Animal; Cognitive Dysfunction; Cytokines; Dexmedetomidine; Hepatic Encephalopathy; Inflammasomes; Liver; Male; Microglia; NLR Family, Pyrin Domain-Containing 3 Protein; Prefrontal Cortex; Rats, Sprague-Dawley; Sleep Wake Disorders | 2021 |